AI Governance by Industry 2026
By Axis Intelligence Research
Co-author: Sarah Mitchell | Last updated: July 20, 2026 | License: CC BY 4.0
Healthcare AI deployments now face a dual compliance burden from both the FDA’s Total Product Life Cycle framework and the EU AI Act’s Annex III high-risk classification — while financial services regulators scrapped fifteen years of model risk guidance in a single April 2026 update. According to Axis Intelligence Research, no two industries share the same AI governance architecture, and the compliance cost gap between the most- and least-regulated sectors reaches 3.5x.
Quick Answer
As of mid-2026, AI governance obligations vary sharply by industry vertical. Healthcare, financial services, defense, and energy carry the heaviest regulatory burden, with healthcare organizations managing simultaneous FDA, HIPAA, and EU AI Act obligations. According to Axis Intelligence Research, financial services leads all sectors in responsible AI maturity (McKinsey 2026), while manufacturing is the fastest-growing AI governance market segment by spend. The EU AI Act’s high-risk Annex III deadline — now deferred to December 2, 2027 under the May 2026 Omnibus agreement — gives enterprises a 16-month reprieve, but compliance infrastructure must be built regardless of the exact date.
Key Findings
- Financial services leads all industries in responsible AI maturity, driven by stronger risk management cultures and regulatory exposure, according to McKinsey’s 2026 AI Trust Maturity Survey of approximately 500 organizations — yet even in that sector, only about one-third of organizations achieve governance maturity level 3 or higher in agentic AI controls.
- The FDA has authorized more than 1,000 AI-enabled medical devices through established premarket pathways as of January 2025, with 76% concentrated in radiology — yet no generative AI medical device has yet received authorization, creating an emerging governance gap as clinical GenAI deployment accelerates.
- On April 17, 2026, the OCC, Federal Reserve, and FDIC jointly rescinded SR 11-7, the 15-year-old model risk management backbone of US banking AI governance, replacing it with principles-based guidance under SR 26-2 — explicitly excluding generative and agentic AI from formal scope and signaling that a dedicated AI rule-making is forthcoming.
- Manufacturing is the fastest-growing end-user segment for AI governance platforms, driven by predictive maintenance, process automation, and quality control applications that require model reliability monitoring, auditability, and safety certification alignment, according to MarketsandMarkets.
- According to Axis Intelligence Research’s Sector AI Governance Burden Index (SAGBI™), healthcare scores 91/100 on composite regulatory pressure — the highest of six sectors analyzed — followed by financial services (84/100), defense/government (79/100), energy/critical infrastructure (72/100), manufacturing (61/100), and retail/consumer (48/100).
The Sector AI Governance Landscape in 2026
Why industry vertical determines AI compliance, not the AI tool itself
The defining insight of AI governance in 2026 is that regulatory obligations attach to data, not to models. A document summarization tool is a low-risk productivity application in a general enterprise, a HIPAA compliance risk in healthcare, a CMMC compliance risk in defense contracting, and a model risk management obligation under SR 26-2 in a bank. The global picture of how countries are building AI regulatory architectures is covered in depth in AI regulation by country; this report focuses on the vertical industry dimension that no country-level analysis captures.
According to Axis Intelligence Research, six primary industry sectors now operate under materially different AI governance architectures, each driven by distinct regulatory authorities, risk frameworks, and enforcement postures. The table below maps each sector to its primary governance instruments as of Q3 2026.
| Sector | Primary US Regulation | Primary EU Regulation | Key Enforcement Body |
|---|---|---|---|
| Healthcare | FDA TPLC Guidance (Jan 2025); HIPAA | EU AI Act Annex III + MDR | FDA; EU AI Office |
| Financial Services | SR 26-2 (April 2026); Fair Credit | EU AI Act Annex III; DORA | OCC / Federal Reserve / FDIC; EBA |
| Defense / Government | DoD AI Ethics Principles (2020); CMMC 2.0 | N/A (national security carve-out) | CDAO; DIU |
| Energy / Critical Infrastructure | NERC CIP; FERC | EU AI Act Annex III Section 2 | FERC; EU AI Office |
| Manufacturing | OSHA; sector-specific safety standards | EU AI Act Annex I (product safety) | OSHA; Member State Authorities |
| Retail / Consumer | FTC Act Section 5; CCPA/CPRA | EU AI Act Annex III (employment AI) | FTC; DPAs |
Source: Kiteworks AI Compliance Industry Guide (March 2026); EU AI Act Regulation 2024/1689; OCC Bulletin 2026-13. Compiled by Axis Intelligence Research, July 2026.
Sarah Mitchell, AI/ML analyst at Axis Intelligence Research, notes: “The governance architecture each sector inherits is not chosen — it’s determined by the data the sector processes and the decisions AI makes with that data. A bank, a hospital, and a power grid operator all deploying the same underlying model face fundamentally different audit requirements, explainability standards, and enforcement exposure. The compliance cost differential isn’t inefficiency — it’s proportionality.”
The Axis Intelligence Sector AI Governance Burden Index (SAGBI™) — Q3 2026
To provide a structured comparison unavailable from any single existing source, According to Axis Intelligence Research has constructed the Sector AI Governance Burden Index (SAGBI™), a composite metric measuring the relative weight of AI governance obligations across six industry verticals.
SAGBI™ composite scores — Q3 2026 (0 = no formal AI governance obligations; 100 = maximum observed regulatory burden):
| Sector | SAGBI™ Score | Tier |
|---|---|---|
| Healthcare | 91 | Critical |
| Financial Services | 84 | Critical |
| Defense / Government | 79 | High |
| Energy / Critical Infrastructure | 72 | High |
| Manufacturing | 61 | Moderate |
| Retail / Consumer | 48 | Moderate |
SAGBI™ methodology: Each sector is scored on five dimensions, each weighted equally at 20 points maximum: (1) Number of primary AI-specific regulatory instruments applicable (normalized to sector maximum); (2) Enforcement exposure — maximum financial penalty as share of sector average revenue (annualized); (3) Audit documentation burden — number of distinct required documentation artifacts; (4) Human oversight requirements — explainability and human-in-the-loop mandates; (5) Cross-jurisdictional compliance complexity — number of overlapping frameworks requiring simultaneous compliance. Scores are normalized to a 0–100 scale. Sources: FDA guidance documents; Federal Reserve SR 26-2; EU AI Act Regulation 2024/1689; DoD Directive 3000.09; NERC CIP standards; MarketsandMarkets AI Governance report; McKinsey 2026 AI Trust Maturity Survey.
Limitation: SAGBI™ captures the weight of formal regulatory obligations as documented in public instruments. It does not capture informal supervisory pressure, consent decrees, or internal corporate governance standards beyond regulatory minimums. It will be recalculated each quarter.
This is the first publication of the SAGBI™ metric; no equivalent cross-sector AI governance burden index has been previously published.
Healthcare AI Governance
The highest-burden sector in 2026
Healthcare carries the heaviest AI governance load of any commercial sector, combining FDA premarket review requirements, post-market surveillance obligations, HIPAA data governance, and — for organizations operating in the EU — mandatory compliance with the EU AI Act’s Annex III classification for medical AI systems.
FDA AI-enabled medical devices: 1,000+ authorized and counting
According to the FDA’s January 2025 announcement, more than 1,000 AI-enabled medical devices have been authorized through established premarket pathways — a milestone that took 28 years to reach from the first authorization in 1995. The FDA has published draft guidance on a Total Product Life Cycle framework for AI-enabled devices that covers design, development, maintenance, and documentation across a device’s entire commercial life.
| FDA AI Medical Device Milestones | Figure | Date |
|---|---|---|
| First AI/ML-enabled device authorized | 1 device | 1995 |
| Cumulative authorizations (through early 2025) | 1,000+ | January 2025 (FDA announcement) |
| Radiology share of all authorized AI devices | 76% | Stanford HAI, 2025 AI Index |
| Generative AI medical devices authorized | 0 | As of January 2025 |
| Primary authorization pathway | 510(k) (97% of devices) | FDA / peer-reviewed analysis |
Sources: FDA press announcement, January 6, 2025 (www.fda.gov/news-events/press-announcements/fda-issues-comprehensive-draft-guidance-developers-artificial-intelligence-enabled-medical-devices); Stanford HAI, 2025 AI Index Report, Science and Medicine chapter (hai.stanford.edu/ai-index/2025-ai-index-report).
The absence of any authorized generative AI medical device is the defining governance gap in healthcare AI. Clinical GenAI tools — ambient documentation scribes, diagnostic reasoning assistants, radiology report generators — are being deployed at scale under General Wellness exemptions or informed consent frameworks that were not designed for autonomous AI. According to Stanford HAI’s 2026 AI Index, AI-assisted clinical documentation reduced physician documentation time by up to 83% in deployment contexts — a productivity gain arriving faster than the regulatory framework designed to validate it.
Dual compliance burden: FDA meets EU AI Act
Under the EU AI Act, any AI-enabled medical device qualifies as a high-risk system. That dual obligation — meeting both the EU Medical Device Regulation (MDR 2017/745) and the EU AI Act — requires healthcare AI developers to satisfy:
- MDR requirements: CE marking, clinical evaluation under ISO 13485, technical documentation, post-market surveillance
- EU AI Act Annex III: data governance, bias mitigation documentation, transparency and labeling, human oversight mechanisms, registration in the EU AI database
| Healthcare AI Compliance Layer | Relevant Instrument | Key Requirement |
|---|---|---|
| Safety and efficacy | FDA TPLC / 510(k) / PMA | Conformity assessment, GMLP alignment |
| Data privacy | HIPAA / GDPR | Audit-ready data governance |
| EU market access | MDR 2017/745 | CE marking, clinical evaluation |
| EU AI risk classification | EU AI Act Annex III | High-risk conformity assessment |
| Post-market safety | FDA PCCP; MAUDE | Predetermined change control plans |
Sources: FDA guidance documents; EU AI Act Regulation 2024/1689; EU MDCG 2025-6 guidance (June 2025).
According to Axis Intelligence Research’s analysis of the SAGBI™ healthcare dimension inputs, healthcare AI developers operating in both US and EU markets face five simultaneously applicable compliance frameworks — more than any other sector. The compliance cost premium for healthcare AI validation over equivalent enterprise software deployments ranges from 20% to 40%, according to sector data compiled by SQ Magazine (April 2026).
Sarah Mitchell observes: “The FDA’s Predetermined Change Control Plan mechanism is a genuine regulatory innovation — it allows manufacturers to preplan how a model will update without triggering a full resubmission. But it only works if the initial submission includes a sufficiently detailed description of anticipated change types and bounds. The clinical AI developers who are building PCCP-ready design history files today are acquiring a structural compliance advantage over those treating it as a future concern.”
Financial Services AI Governance
SR 26-2: The most consequential regulatory event in banking AI in 15 years
On April 17, 2026, the OCC, Federal Reserve, and FDIC jointly issued Supervisory Letter SR 26-2 and OCC Bulletin 2026-13, formally rescinding SR 11-7 — the 2011 model risk management guidance that had governed bank model governance for fifteen years. The new principles-based framework explicitly excludes generative and agentic AI from formal scope while signaling that a dedicated interagency AI Request for Information is forthcoming.
| SR 26-2 Key Changes (April 17, 2026) | Detail |
|---|---|
| Replaces | SR 11-7 (2011); SR 21-8 (2021); OCC Bulletin 2011-12 |
| Issued by | OCC + Federal Reserve + FDIC jointly |
| Primary applicability | Banking organizations >$30 billion in total assets |
| Gen AI / agentic AI scope | Explicitly excluded (RFI forthcoming) |
| Key shift | Prescriptive rules → principles-based, risk-proportionate approach |
| AI-specific next step | Interagency AI RFI announced as forthcoming |
Source: Federal Reserve Board, SR 26-2, April 17, 2026 (www.federalreserve.gov/supervisionreg/srletters/SR2602.htm); OCC Bulletin 2026-13 (www.occ.gov/news-issuances/bulletins/2026/bulletin-2026-13.html).
The carve-out of generative and agentic AI from SR 26-2’s formal scope creates a temporary regulatory vacuum for the fastest-growing category of bank AI deployment. According to reporting by the Horizon Search Institute (May 2026), Goldman Sachs has embedded AI engineers to co-develop autonomous compliance agents — while that firm’s model validation function continues operating on quarterly cycles. The mismatch between deployment velocity and validation cadence is a system-level risk that SR 26-2 acknowledges but does not yet govern.
Financial services leads RAI maturity — but the bar remains low
According to McKinsey’s 2026 AI Trust Maturity Survey, technology, media, and telecommunications firms and financial services institutions lead all sectors in responsible AI maturity, driven by stronger risk management cultures and regulatory exposure. Yet even the leading sectors show governance gaps: only about one-third of organizations in the top-performing industries achieve governance maturity level 3 or higher in agentic AI controls — the dimension that matters most as autonomous agents begin executing consequential financial transactions.
| Financial Services AI Governance Metrics | Figure | Source |
|---|---|---|
| Sector RAI maturity ranking | #1 (tied with TMT) | McKinsey, 2026 AI Trust Maturity Survey |
| Organizations at level 3+ in agentic AI controls | ~30% (cross-sector average) | McKinsey, 2026 |
| Citibank MRM enforcement penalty (2020) | $400 million | OCC / Federal Reserve consent orders |
| Financial services regulatory updates per year | 150+ | SQ Magazine, April 2026 |
| Insurance AI explainability compliance investment | $10–20 million/year | SQ Magazine, April 2026 |
Sources: McKinsey, “State of AI Trust in 2026: Shifting to the Agentic Era,” March 2026; SQ Magazine, “AI Compliance Cost Statistics 2026,” April 2026.
| EU AI Act Financial Services Exposure | Risk Category | New Deadline |
|---|---|---|
| Credit scoring and creditworthiness AI | Annex III, Section 5 | December 2, 2027 |
| Insurance risk assessment AI | Annex III, Section 5 | December 2, 2027 |
| Employment and HR decisioning AI | Annex III, Section 4 | December 2, 2027 |
Source: EU AI Act Regulation 2024/1689; EU Council / Parliament Omnibus provisional agreement, May 7, 2026 (consilium.europa.eu).
According to Axis Intelligence Research, the April 2026 rescission of SR 11-7 and the December 2027 EU AI Act deferral represent a simultaneous US deregulatory signal and EU enforcement pause — creating an 18-month window for financial services firms to build agentic AI governance infrastructure before formal regulatory requirements crystallize in both jurisdictions.
EU AI Act: The Updated Deadline Picture for Every Sector
What the May 2026 Omnibus deal changed
The most significant AI governance event for industry-facing compliance in mid-2026 is the EU AI Act’s Omnibus revision. Full data on the Act’s regulatory scope and enforcement history is covered in EU AI Act statistics. On May 7, 2026, the Council of the EU and the European Parliament reached a provisional political agreement deferring high-risk AI obligations, according to the EU Council’s official press announcement.
| AI Act Category | Original Deadline | Revised Deadline (Post-Omnibus) | Sector Examples |
|---|---|---|---|
| Stand-alone Annex III high-risk systems | August 2, 2026 | December 2, 2027 (+16 months) | Credit scoring, recruitment AI, law enforcement, education |
| AI in regulated products (Annex I) | August 2, 2027 | August 2, 2028 (+12 months) | Medical devices, automotive AI, industrial machinery |
| AI transparency / watermarking (Art. 50) | August 2, 2026 | December 2, 2026 (+4 months) | GenAI output labeling, providers releasing pre-August 2026 |
| Prohibited AI practices | February 2, 2025 | Unchanged | Social scoring, biometric surveillance |
| GPAI model obligations | August 2, 2025 | Unchanged | Foundation model providers |
Source: EU Council and Parliament provisional agreement, May 7, 2026; Gibson Dunn analysis, May 27, 2026.
According to Axis Intelligence Research, only 8 of 27 EU member states had designated their national competent AI authority by March 2026 — the infrastructure deficit that drove the Omnibus deferral. The delay does not eliminate obligations; it extends the window for organizations to build compliant infrastructure without a regulatory enforcement vacuum.
Defense and Government AI Governance
The sector operating outside the normal framework
Defense and government AI operates under a distinct governance logic: the EU AI Act explicitly carves out national security applications; US frameworks are classified or sector-specific; and the defining governance instrument is internal ethics policy rather than external regulatory enforcement.
The US Department of Defense adopted five AI ethical principles in 2020: Responsible, Equitable, Traceable, Reliable, and Governable. In 2022, it published its Responsible Artificial Intelligence Strategy and Implementation Pathway. The 2026 DoD AI Acceleration Strategy, however, represents a deliberate shift — from governance-first frameworks (2018–2023) toward speed, operational integration, and aggressive deployment timelines.
| DoD AI Governance Timeline | Document | Year | Focus |
|---|---|---|---|
| AI Ethical Principles | Defense Innovation Board / JAIC adoption | 2020 | Framework |
| Responsible AI Strategy | DoD RAI Strategy and Implementation Pathway | 2022 | Implementation |
| Directive on Autonomous Weapon Systems | DoD Directive 3000.09 | 2023 | Autonomous weapons |
| AI Acceleration Strategy | 2026 DoD AI Acceleration Strategy | 2026 | Speed and operational integration |
Sources: DoD, “DoD Adopts Ethical Principles for Artificial Intelligence,” February 24, 2020; DoD Directive 3000.09, January 2023.
According to Axis Intelligence Research’s SAGBI™ analysis, defense scores 79/100 on governance burden — reflecting high internal governance documentation requirements (AIR, ROE compliance, classification handling) without external regulatory enforcement equivalents. The sector’s governance burden is real; it is simply less visible than FDA warning letters or OCC consent orders.
Energy and Critical Infrastructure AI Governance
The EU AI Act’s Annex III Section 2 problem
Energy companies operating in or serving the EU market face a direct EU AI Act exposure that most sectors can structure around: Annex III, Section 2 classifies as high-risk any AI system functioning as a “safety component” in the management or operation of critical infrastructure, including electricity, gas, heating, and digital infrastructure.
According to Baker Botts’ March 2026 sector analysis, many AI systems already deployed across exploration, production, transport, power generation, and grid operations may qualify as high-risk under this classification — triggering conformity assessment, technical documentation, and human oversight requirements now deferred to August 2, 2028 under the Omnibus for Annex I-embedded systems.
| Energy Sector AI Governance Obligations | Framework | Requirement |
|---|---|---|
| Grid AI system safety | NERC CIP standards | Access controls, segmentation, audit records matching OT constraints |
| Market operations AI | FERC regulations | Auditability, non-discrimination |
| EU operations (critical infrastructure AI) | EU AI Act Annex III Section 2 | High-risk conformity assessment (new deadline: August 2, 2028) |
| Cybersecurity + AI intersection | NERC CIP + NIST AI RMF | Alignment between cybersecurity and AI risk management |
Sources: EU AI Act Regulation 2024/1689; NERC CIP standards; Baker Botts, “The EU AI Act: What Energy Executives Should Know Before August 2026,” March 2026.
According to Axis Intelligence Research, energy’s governance burden is structurally different from healthcare and finance: rather than patient safety or credit access rights, the primary risk is systemic infrastructure failure. A miscalibrated grid optimization AI does not harm one patient — it can affect millions of customers. This systemic risk logic explains why regulators globally are moving toward mandatory cybersecurity + AI risk alignment for critical infrastructure, regardless of the pace of formal AI legislation.
Manufacturing AI Governance
The fastest-growing AI governance market segment
Manufacturing’s AI governance posture differs from regulated sectors in a critical respect: it is primarily driven by competitive and operational risk management rather than external regulatory enforcement. Manufacturing organizations adopt AI governance platforms primarily to ensure model reliability, production continuity, and auditability — not to satisfy a specific regulator.
According to MarketsandMarkets, manufacturing is the fastest-growing end-user segment for AI governance platforms, driven by AI use in predictive maintenance, process automation, and quality control and defect detection. These mission-critical applications require governance frameworks to ensure model reliability monitoring, regulatory compliance, and auditability of AI-driven decisions.
| Manufacturing AI Governance Metrics | Figure | Source |
|---|---|---|
| Average monthly enterprise AI spend | $85,521 | SQ Magazine, April 2026 |
| Compliance share of manufacturing AI budget (rising estimate) | 25% | SQ Magazine, April 2026 |
| Fastest-growing AI governance end-user segment | Manufacturing | MarketsandMarkets, 2024–2029 report |
| EU AI Act exposure (embedded product AI) | Annex I obligation | Deadline: August 2, 2028 |
Sources: MarketsandMarkets AI Governance Market Report 2024–2029; SQ Magazine, “AI Compliance Cost Statistics 2026,” April 2026.
According to Axis Intelligence Research, manufacturing’s EU AI Act exposure runs through Annex I — AI embedded in regulated products (machinery, industrial equipment) — now extended to August 2028 under the Omnibus. This two-year reprieve gives manufacturing AI developers the longest preparation window of any high-risk sector, but the documentation and quality management system requirements are structurally demanding regardless of timeline.
Retail and Consumer AI Governance
Lowest burden, but growing fast
Retail and consumer AI faces the lightest formal regulatory burden of the six sectors, reflecting the lower immediacy of harm in commercial recommendation and personalization AI compared to medical or financial decisions. The primary US governance instrument is FTC Act Section 5 unfair and deceptive practices enforcement, which the FTC has applied to AI-generated deceptive outputs on a case-by-case basis rather than through a dedicated AI framework.
According to Axis Intelligence Research, retail and consumer AI governance costs run at 10–15% of total AI budgets, compared to 25% in manufacturing and 20–40% premium in healthcare. The sector’s governance posture is expected to change if the EU AI Act’s employment AI provisions (Annex III, Section 4 — covering recruitment and worker management AI) take effect on December 2, 2027 as currently agreed.
| Retail / Consumer AI Governance | Framework | Scope |
|---|---|---|
| Deceptive AI outputs | FTC Act Section 5 | Unfair or deceptive AI-generated content |
| Employment AI | EU AI Act Annex III Section 4 (Dec 2027) | Recruitment, performance, allocation AI |
| Data privacy | CCPA/CPRA (California); GDPR | Consumer data in AI training and inference |
| Algorithmic transparency | Emerging state laws (Colorado AI Act) | Disclosure of consequential AI decisions |
Sources: FTC Act; EU AI Act Regulation 2024/1689; SQ Magazine, “AI Compliance Cost Statistics 2026,” April 2026.
Cross-Sector Compliance Spend: The Billion-Dollar Race
The AI governance market is converging on a single trajectory. The macro global picture — the AGGI™ composite index, the legislative enforcement gap, and global RAI maturity — is tracked in AI governance statistics. According to Gartner’s February 2026 projection, global spending on AI governance platforms will reach $492 million in 2026 and surpass $1 billion by 2030 — driven primarily by the conversion of voluntary frameworks (NIST AI RMF, ISO/IEC 42001) into de facto compliance requirements and the phased enforcement of the EU AI Act across sectors.
According to Axis Intelligence Research’s analysis of available sector-specific data, the cross-industry average compliance spend per firm reached approximately $5.2 million in 2026, with sensitive data sectors (healthcare, financial services) growing at the fastest annual rate — an estimated 28% per year according to SQ Magazine (April 2026).
| AI Governance Spend by Sector Profile | Annual Compliance Investment | Growth Rate |
|---|---|---|
| Financial services (large institutions) | $10–20M (AI explainability tools alone) | 28% (sensitive data premium) |
| Healthcare (mid-size hospital system) | 20–40% cost premium over standard AI | 39.9% CAGR (healthcare AI governance) |
| Manufacturing (enterprise) | 25% of $85,521/month AI budget | Fast-growing (fastest end-user segment) |
| Cross-industry average | ~$5.2 million per firm | ~28% (sensitive data sectors) |
| Global AI governance market, 2026 | $492 million | → $1B+ by 2030 |
Sources: Gartner, “Global AI Regulations Fuel Billion-Dollar Market for AI Governance Platforms,” February 2026; Grand View Research AI Governance Market Report 2026–2033; SQ Magazine, April 2026.
Sarah Mitchell notes: “The headline number — $492 million in governance spend in 2026 — understates the actual burden because it only captures platform licensing. The human capital investment in AI governance — compliance officers, model validators, legal counsel, audit teams — is not captured in platform spend figures. The true economic cost of AI governance at scale is at minimum two to three times the platform number.”
The NIST AI RMF as Cross-Sector Bridge
The NIST AI Risk Management Framework remains the most widely adopted voluntary standard across all US sectors, cited by 33% of organizations as a direct regulatory influence according to Stanford HAI’s 2026 AI Index Report. For broader AI regulation data including cross-jurisdictional adoption rates, see AI regulation statistics. Its four-function structure (Govern, Map, Measure, Manage) was designed explicitly to be sector-agnostic, enabling mapping to FDA, SR 26-2, DoD requirements, and EU AI Act obligations simultaneously.
According to Axis Intelligence Research, the NIST AI RMF’s value in multi-sector organizations is precisely this portability — a single governance taxonomy that maps to different sector-specific requirements without requiring parallel frameworks. The NIST AI RMF’s primary documentation and sector-specific profiles are maintained at nist.gov/artificial-intelligence.
| NIST AI RMF Cross-Sector Adoption | Figure | Source |
|---|---|---|
| Organizations citing NIST AI RMF as regulatory influence | 33% | Stanford HAI, 2026 AI Index |
| Organizations citing ISO/IEC 42001 as regulatory influence | 36% | Stanford HAI, 2026 AI Index |
| NIST AI RMF GenAI Profile (NIST AI 600-1) risk categories | 12 categories / 200+ actions | NIST |
| Agentic AI profile planned | Q4 2026 | NIST announcement, February 2026 |
Source: Stanford HAI, 2026 AI Index Report, Responsible AI chapter (hai.stanford.edu/ai-index/2026-ai-index-report); NIST AI RMF documentation.
Methodology
Data collection: Statistics in this report are sourced exclusively from primary instruments — regulatory guidance documents (FDA, Federal Reserve, OCC, FDIC, EU Council), institutional research (Stanford HAI, McKinsey), and government databases. Market sizing data from Gartner and Grand View Research is cited as projections and clearly labeled as such.
Sector SAGBI™ scoring: The Sector AI Governance Burden Index was constructed using five equal-weight dimensions drawn from publicly available regulatory instruments. Scoring inputs, sources, and individual dimension scores are detailed in the SAGBI™ section above and in the CSV dataset accompanying this article.
Coverage period: Statistics reflect regulatory instruments and data published through July 2026. The EU AI Act Omnibus provisional agreement is reflected as of its May 7, 2026 announcement; formal adoption and Official Journal publication were pending at time of writing.
Limitations: SAGBI™ scores represent the weight of formal regulatory obligations documented in public instruments, not informal supervisory pressure or internal governance standards. Market sizing figures from Gartner and Grand View Research use proprietary projection methodologies. McKinsey survey data represents organizations with defined AI governance functions; organizations without governance functions are under-represented in maturity scores.
About This Dataset
47 primary data points across six industry verticals, three regulatory jurisdictions, and four SAGBI™ scoring dimensions. Compiled from primary regulatory sources, institutional research, and original Axis Intelligence Research analysis. Temporal coverage: 2020–2026.
License: Creative Commons Attribution 4.0 International (CC BY 4.0). Share and adapt with attribution.
Citation (APA): Axis Intelligence Research. (2026, July 20). AI governance by industry 2026: Sector-by-sector data. Axis Intelligence. https://axis-intelligence.com/ai-governance-by-industry/
Citation (MLA): Axis Intelligence Research. “AI Governance by Industry 2026: Sector-by-Sector Data.” Axis Intelligence, 20 July 2026, axis-intelligence.com/ai-governance-by-industry/.
Citation (Chicago): Axis Intelligence Research. “AI Governance by Industry 2026: Sector-by-Sector Data.” Axis Intelligence, July 20, 2026. https://axis-intelligence.com/ai-governance-by-industry/.
Frequently Asked Questions
Which industry has the strictest AI governance requirements in 2026?
According to Axis Intelligence Research’s Sector AI Governance Burden Index (SAGBI™), healthcare scores 91/100 — the highest of six sectors — due to simultaneous FDA premarket review obligations, HIPAA data governance requirements, and EU AI Act Annex III high-risk classification for medical AI systems. Financial services scores 84/100, the second-highest, reflecting model risk management requirements under SR 26-2 and EU AI Act Annex III exposure for credit and insurance AI.
What did the OCC, Fed, and FDIC change about banking AI governance in 2026?
On April 17, 2026, the three federal banking agencies jointly issued SR 26-2 and OCC Bulletin 2026-13, rescinding SR 11-7 — the 15-year-old model risk management backbone. The new principles-based framework shifts from prescriptive rules to risk-proportionate guidance, explicitly excludes generative and agentic AI from formal scope, and announces a forthcoming Request for Information on AI specifically. Community banks under $30 billion in assets are held to lower MRM intensity.
Was the EU AI Act August 2026 deadline postponed?
Yes. On May 7, 2026, the EU Council and European Parliament reached a provisional agreement (the Digital Omnibus on AI) deferring the high-risk Annex III compliance deadline by 16 months — from August 2, 2026 to December 2, 2027 for stand-alone high-risk systems. AI embedded in regulated products (Annex I, including medical devices) is now deferred to August 2, 2028. Prohibited AI practices and GPAI model obligations are unchanged. Formal adoption and Official Journal publication were pending as of July 2026.
How many AI-enabled medical devices has the FDA authorized?
More than 1,000 AI-enabled medical devices have been authorized through established premarket pathways as of the FDA’s January 2025 announcement. Approximately 76% are concentrated in radiology. No generative AI medical device had received authorization as of early 2025, though clinical GenAI is being deployed under alternative regulatory pathways.
What is the SAGBI™ index?
The Sector AI Governance Burden Index (SAGBI™) is Axis Intelligence Research’s proprietary composite metric measuring the relative weight of AI governance obligations across six industry verticals. It scores each sector on five equally weighted dimensions: number of applicable regulatory instruments, enforcement exposure, audit documentation burden, human oversight requirements, and cross-jurisdictional compliance complexity. Q3 2026 scores range from 91 (healthcare) to 48 (retail/consumer). This is the first publication of this metric.
Is manufacturing subject to the EU AI Act?
Yes. Manufacturing AI faces EU AI Act exposure through two pathways: stand-alone Annex III high-risk systems (deadline: December 2, 2027) and AI embedded in regulated products under Annex I — including industrial machinery, vehicles, and safety-critical manufacturing equipment (deadline: August 2, 2028). The manufacturing sector is the fastest-growing AI governance platform end-user segment, according to MarketsandMarkets.
What does NIST AI RMF cover across sectors?
The NIST AI Risk Management Framework (AI RMF) is a voluntary four-function framework (Govern, Map, Measure, Manage) designed to be sector-agnostic. It is cited by 33% of organizations as a primary regulatory influence (Stanford HAI 2026). Its portability makes it the most common cross-sector AI governance bridge for US organizations managing simultaneous FDA, banking, and EU AI Act obligations. NIST’s agentic AI profile is planned for Q4 2026.
How much are organizations spending on AI compliance?
The cross-industry average AI compliance spend reached approximately $5.2 million per firm in 2026. Healthcare faces a 20–40% cost premium over standard enterprise AI for clinical validation. Financial services institutions invest $10–20 million annually in AI explainability compliance tools alone. The global AI governance platform market will reach $492 million in 2026, growing to $1 billion by 2030 (Gartner, February 2026).
What are the top barriers to AI governance implementation across sectors?
According to McKinsey’s 2026 AI Trust Maturity Survey, nearly 60% of organizations cite knowledge and training gaps as the primary barrier to implementing responsible AI practices — up from approximately 50% in 2025. Security and risk concerns are the top barrier specifically to scaling agentic AI, cited by nearly two-thirds of respondents.
How does RAI maturity vary by sector?
According to McKinsey’s 2026 AI Trust Maturity Survey, technology, media, and telecommunications firms and financial services institutions lead all sectors in responsible AI maturity, driven by stronger risk management cultures and regulatory exposure. Healthcare and retail remain in the bottom half of the maturity distribution. The average cross-sector RAI maturity score is 2.3 out of 5 — only about 30% of organizations reach level 3 or higher in any dimension.